Biomedical (basic)

Ended Definitive Contract Awarded Last action

Contract number
HHSN261200900069C
Awardee
Awarding agency
Obligated
$149,760

Award facts

Opportunity
  • 9900115 Solicitation number
Contract value 100% obligated
$149,760.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Alameda, CA 94502, USA
Research
SBIR Program Phase I Action
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope 1 $0
Original award $149,760

About this award

This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Singulex, Inc., a small business. The contract is for a Small Business Innovation Research (SBIR) Program Phase I research project in the biomedical field, with a firm fixed price of $149,760 and a period of performance ending on April 30, 2010. As an SBIR Phase I award, this contract supports early-stage research and development efforts. The contract was awarded on September 30, 2009.

Quick answers

Who was awarded contract HHSN261200900069C?

HHSN261200900069C was awarded to Singulex, Inc. by National Cancer Institute (National Institutes of Health) on September 30, 2009.

How much is contract HHSN261200900069C worth?

The government has obligated $149,760 on HHSN261200900069C.

Was contract HHSN261200900069C competed?

The extent of competition for HHSN261200900069C was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award